Dr Reddy's Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccine Sputnik V, on Tuesday said it expects the first lot of stock from Russian Direct Investment Fund by May end. In September 2020, Dr Reddys and RDIF entered into a partnership to conduct clinical trials of Sputnik V, developed by the …
The Drug Controller General of India has approved the restricted emergency use of the Sputnik V vaccine late on Monday night. With this, India now has three vaccines against COVID-19, including Covishield — the Oxford-Astrazeneca vaccine manufactured by the Serum Institute of India — and Bharat Biotech’s Covaxin According to a release issued by the Russian Direct Investment Fund, India …
